[1]
I. Yilmaz, B. Bilir, M. Dogan, N. Karaarslan, and H. Ozbek, “Evaluation of inflammatory and biochemical markers in COVID-19 patients treated with tocilizumab alone or with the combination of tocilizumab and convalescent plasma transfusion”, annalsmedres, vol. 29, no. 7, pp. 770–776, Jul. 2022.